Access to Innovative Medicines: Regulation Change and Factors Associated with Drug Approval Lag in Malaysia.

Background: Drug approval lag is the time difference for new medicine to obtain marketing authorization approval in the study country compared to the first global approval. Drug approval lag delays the availability of innovative medicine to patients. This may lead to delay in treatment and severe public health implications.